Sept 29 (Reuters) – Metsera Inc: * METSERA REPORTS POSITIVE PHASE 2B RESULTS FOR FIRST- AND BEST-IN-CLASS ULTRA-LONG ACTING GLP-1 RA CANDIDATE MET-097I, ENABLING RAPID TRANSITION INTO PHASE 3 * METSERA INC – MET-097I SHOWS 14.1% WEIGHT LOSS AFTER 28 WEEKS * METSERA INC – MET-097I SHOWS CLASS-LEADING TOLERABILITY IN TRIALS * METSERA INC – DATA SUPPORTS PHASE 3 INITIATION IN LATE 2025 Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Lisa Richwine LOS ANGELES (Reuters) -How does a person summarize the 45-year career of…
Mark your calendar — the GTBS coin is officially launching on December 25. Dubai [UAE],…
Mumbai (Maharashtra) [India], November 17: Bright Outdoor Media Limited, one of India’s leading and most…
New Delhi [India], November 17: Breaking stereotypes and igniting important conversations, the trailer of Me…
Coimbatore (Tamil Nadu) [India], November 17: Selecting the ideal university can determine how your future…
VIDEO SHOWS: AUSTRALIAN CRICKET TEAM TRAINING / SOUNDBITES FROM AUSTRALIAN BOWLER SCOTT BOLAND SHOWS: PERTH,…